Blog

Expert Analysis: Deprescribing, Sarcopenia and Safer Geriatric Trials

Five expert insights on deprescribing, sarcopenia treatments, geriatric oncology, and building safer trials for frail older adults—plus survey findings and trainee pathways to advance care and research.

Actionable Trials for Seniors: Flu Shots, Cancer, Heart & Meds

Practical Q&A for seniors and caregivers: flu vaccine options, joining breast cancer and heart trials, and deprescribing studies — plus a short checklist and encouraging guidance.

How Can Deprescribing Trials Boost Senior Safety and Mobility?

Deprescribing trials reduce polypharmacy harms and restore mobility for older adults. This analysis links trial design, fall-prevention, immune strategies, caregiver-friendly dementia options, and global regulatory and outcome metrics for actionable practice change.

Case Study: Geriatric Oncology Trials, Deprescribing & Telerehab Wins

Analytical case study on geriatric oncology trials, deprescribing, wearables for fall detection, and telerehab — data-driven trends, guideline updates, and practical steps for patients and trainees.

Senior Case Studies: Telehealth, Polypharmacy, Lung Studies & Tinnitus

Patient-first case studies show how seniors join trials via telehealth, what caregivers should ask about polypharmacy, where to find lung cancer studies for older adults, and how seniors can participate in tinnitus research.